Dasarathy Y, Fanburg B L
New England Medical Center Hospital, Pulmonary Division, Boston, MA 02111.
Biochim Biophys Acta. 1989 Jan 17;1010(1):16-9. doi: 10.1016/0167-4889(89)90178-x.
Calcium ionophore A23187 (0.3-0.4 microM) elevated cellular angiotensin-converting enzyme activity (ACE) 2-7-fold after 48 h incubation with bovine pulmonary artery endothelial cells in culture. Cycloheximide (0.1 micrograms/ml) blocked the elevation in ACE produced by A23187. The increase in ACE was inhibited by 0.2 mM EGTA, 50 microM verapamil and 50 microM nifedipine, and was not associated with changes in cellular cAMP. Melittin, a phospholipase A2 activator, or addition of exogenous arachidonic acid failed to reproduce the elevation, and indomethacin only partially blocked the A23187 effect. The elevation of ACE was also inhibited by the calcium-calmodulin inhibitor, calmidazolium. Thus, we postulate that the ionophore A23187 elevates ACE in endothelial cells through a calcium-dependent mechanism other than phospholipase A2 activation. The elevation depends on new protein synthesis and involves calcium-calmodulin-dependent cellular mechanisms.
在体外培养的牛肺动脉内皮细胞中,钙离子载体A23187(0.3 - 0.4微摩尔)在孵育48小时后可使细胞血管紧张素转换酶(ACE)活性升高2 - 7倍。放线菌酮(0.1微克/毫升)可阻断A23187引起的ACE升高。0.2毫摩尔乙二醇双乙醚二胺四乙酸(EGTA)、50微摩尔维拉帕米和50微摩尔硝苯地平可抑制ACE的升高,且其升高与细胞环磷酸腺苷(cAMP)的变化无关。蜂毒素(一种磷脂酶A2激活剂)或添加外源性花生四烯酸未能重现这种升高,吲哚美辛仅部分阻断A23187的作用。钙调蛋白抑制剂卡咪唑也可抑制ACE的升高。因此,我们推测离子载体A23187通过一种不同于磷脂酶A2激活的钙依赖性机制升高内皮细胞中的ACE。这种升高依赖于新蛋白质的合成,并涉及钙调蛋白依赖性细胞机制。